Dr. Behling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Spruce St
Philadelphia, PA 19107Phone+1 215-829-5442
Education & Training
- University of Pennsylvania Health System GI/Hepatic PathologyFellowship, Selective Pathology, 2012 - 2013
- University of Pennsylvania Health SystemFellowship, Molecular Genetic Pathology, 2011 - 2012
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Pathology-Anatomic and Clinical, 2007 - 2011
- Perelman School of Medicine at the University of PennsylvaniaClass of 2004
Certifications & Licensure
- NJ State Medical License 2013 - 2025
- PA State Medical License 2007 - 2024
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 19 citationsIncreased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinomaKathryn C. Behling, Amy H. Tang, Boris Freydin, Inna Chervoneva, Sameep Kadakia
Breast Cancer Research and Treatment. 2011-10-01 - 107 citationsInhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agentsAlberto Auricchio, K.C. Behling, Albert M. Maguire, Erin E. O'Connor, Jean Bennett
Molecular Therapy. 2002-10-01 - 38 citationsAbundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation.Blaine W. Robinson, Kathryn C. Behling, Manish Gupta, Alena Y. Zhang, Jonni S. Moore
British Journal of Haematology. 2008-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: